Advertisement

Topics

Senate reauthorizes FDA to collect fees from drugmakers

09:58 EDT 3 Aug 2017 | Reuters

(Reuters) - The U.S. Senate on Thursday passed a bill allowing the Food and Drug Administration to continue collecting fees from drug companies to review new product applications.

Original Article: Senate reauthorizes FDA to collect fees from drugmakers

NEXT ARTICLE

More From BioPortfolio on "Senate reauthorizes FDA to collect fees from drugmakers"

Quick Search
Advertisement
 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...